Keywords: fournier, sales, advance, independent, french, pharmaceutical, company
Fournier's Sales Advance 8.2% In 1996
Article | 12 May 1997
The independent French pharmaceutical company Fournier achieved growthin sales in 1996 of 8.2% to 3.2 billion French francs ($552.3 million). Its director general, Bernard ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
